Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: yes.

× No keyword cloud information.

7 in total

1. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis.

Authors: Andreas Charidimou; Gregoire Boulouis; Steven M Greenberg; Anand Viswanathan
Journal: Neurology Date: 2019-11-15 Impact factor: 9.910

Review 2. Antithrombotic treatment after stroke due to intracerebral haemorrhage.

Authors: Luke A Perry; Eivind Berge; Joshua Bowditch; Elisabeth Forfang; Ole Morten Rønning; Graeme J Hankey; Elmer Villanueva; Rustam Al-Shahi Salman
Journal: Cochrane Database Syst Rev Date: 2017-05-25

Review 3. Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review.

Authors: Maximiliano A Hawkes; Alejandro A Rabinstein
Journal: Neurol Clin Pract Date: 2018-02

4. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

Authors: Koen M van Nieuwenhuizen; H Bart van der Worp; Ale Algra; L Jaap Kappelle; Gabriel J E Rinkel; Isabelle C van Gelder; Roger E G Schutgens; Catharina J M Klijn
Journal: Trials Date: 2015-09-04 Impact factor: 2.279

Resumption of oral anticoagulation after warfarin-associated intracerebral hemorrhage: yes.

1. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis.

Review 2. Antithrombotic treatment after stroke due to intracerebral haemorrhage.

Review 3. Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review.

4. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.

Review 5. Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.

Review 6. Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.

7. Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes.